advertisement
Zemba M 14
Showing records 1 to 14 | Display all abstracts from Zemba M107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Zemba M
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Romanitan MO
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Dumitrescu OM
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Popa-Cherecheanu M
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Dumitrescu OM; Gheorghe AG
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Vasile VA
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Radu M
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Stanca S
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Ionescu MA
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Iancu G; Zemba M
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Vatafu A
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Branisteanu D
Diagnostics (Basel, Switzerland) 2023; 13:
107539 Ocular Complications of Radiotherapy in Uveal Melanoma
Dinu V
Cancers 2023; 15:
108355 Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders-A Review
Iancu R; Pirvulescu RA
Diagnostics (Basel, Switzerland) 2023; 13:
